Gerald McLaughlin
2019
In 2019, Gerald McLaughlin earned a total compensation of $1.4M as President and Chief Executive Officer at Neos Therapeutics, a 56% decrease compared to previous year.
Compensation breakdown
| Bonus | $42,000 |
|---|---|
| Non-Equity Incentive Plan | $226,600 |
| Option Awards | $604,571 |
| Salary | $513,307 |
| Other | $12,955 |
| Total | $1,399,433 |
McLaughlin received $604.6K in option awards, accounting for 43% of the total pay in 2019.
McLaughlin also received $42K in bonus, $226.6K in non-equity incentive plan, $513.3K in salary and $13K in other compensation.
Rankings
In 2019, Gerald McLaughlin's compensation ranked 7,676th out of 13,971 executives tracked by ExecPay. In other words, McLaughlin earned more than 45.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,676 out of 13,971 | 45th |
Division Manufacturing | 2,992 out of 5,695 | 48th |
Major group Chemicals And Allied Products | 1,124 out of 2,194 | 49th |
Industry group Drugs | 958 out of 1,880 | 49th |
Industry Pharmaceutical Preparations | 710 out of 1,392 | 49th |
Source: SEC filing on April 21, 2020.
McLaughlin's colleagues
We found two more compensation records of executives who worked with Gerald McLaughlin at Neos Therapeutics in 2019.